MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Everolimus

Everolimus 2.5mg tablets

No stability information

Stability notes for Everolimus 2.5mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Everolimus 2.5mg tablets
Afinitor 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
Everolimus 2.5mg tablets (A A H Pharmaceuticals Ltd)
Everolimus 2.5mg tablets (Accord-UK Ltd)
Everolimus 2.5mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Everolimus 2.5mg tablets (Martindale Pharmaceuticals Ltd)
Everolimus 2.5mg tablets (Sandoz Ltd)
Everolimus 2.5mg tablets (Teva UK Ltd)
Votubia 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)

Everolimus 2mg dispersible tablets sugar free

No stability information

Stability notes for Everolimus 2mg dispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Votubia 2mg dispersible tablets (Novartis Pharmaceuticals UK Ltd)

Everolimus 3mg dispersible tablets sugar free

No stability information

Stability notes for Everolimus 3mg dispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Votubia 3mg dispersible tablets (Novartis Pharmaceuticals UK Ltd)

Everolimus 5mg dispersible tablets sugar free

No stability information

Stability notes for Everolimus 5mg dispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Votubia 5mg dispersible tablets (Novartis Pharmaceuticals UK Ltd)

Everolimus 5mg tablets

No stability information

Stability notes for Everolimus 5mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Everolimus 5mg tablets
Afinitor 5mg tablets (Novartis Pharmaceuticals UK Ltd)
Everolimus 5mg tablets (A A H Pharmaceuticals Ltd)
Everolimus 5mg tablets (Accord-UK Ltd)
Everolimus 5mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Everolimus 5mg tablets (Martindale Pharmaceuticals Ltd)
Everolimus 5mg tablets (Sandoz Ltd)
Everolimus 5mg tablets (Teva UK Ltd)
Votubia 5mg tablets (Novartis Pharmaceuticals UK Ltd)

Everolimus 10mg tablets

No stability information

Stability notes for Everolimus 10mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Everolimus 10mg tablets
Afinitor 10mg tablets (Novartis Pharmaceuticals UK Ltd)
Everolimus 10mg tablets (A A H Pharmaceuticals Ltd)
Everolimus 10mg tablets (Accord-UK Ltd)
Everolimus 10mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Everolimus 10mg tablets (Martindale Pharmaceuticals Ltd)
Everolimus 10mg tablets (Sandoz Ltd)
Everolimus 10mg tablets (Teva UK Ltd)
Votubia 10mg tablets (Novartis Pharmaceuticals UK Ltd)

Everolimus 250microgram tablets

No stability information

Stability notes for Everolimus 250microgram tablets

There are no stability notes for this medicine.

Supplier

Certican 0.25mg tablets (Novartis Pharmaceuticals UK Ltd)

Everolimus 750microgram tablets

No stability information

Stability notes for Everolimus 750microgram tablets

There are no stability notes for this medicine.

Supplier

Certican 0.75mg tablets (Novartis Pharmaceuticals UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.